Figure 1 | Scientific Reports

Figure 1

From: Slow reduction of IP-10 Levels predicts HBeAg seroconversion in chronic hepatitis B patients with 5 years of entecavir treatment

Figure 1

Dynamic change of cytokines/chemokines in patients with CHB during antiviral treatment.

In patients with or without HBeAg seroconversion, the levels of cytokines and chemokines declined significantly after 1 year of antiviral treatment. Serum levels of cytokines and chemokines showed opposite trends compared with the first year, except that the levels of IL-4, IL-6, and MIP-1α continued to decrease in both groups.

Back to article page